Também conhecido como
SMA
Anti-Smooth Muscle Antibody
ASMA
F-Actin Antibody
ACTA
Nome formal
Smooth Muscle Antibody
Este artigo foi revisto pela última vez em
Este artigo foi modificado pela última vez em
12 de Maio de 2018.
At a Glance
Why Get Tested?
To help diagnose chronic active autoimmune hepatitis and distinguish it from other causes of liver injury
When To Get Tested?
When a patient has hepatitis that the doctor suspects may be due to an autoimmune-related process
Sample Required?
A blood sample drawn from a vein in your arm
Test Preparation Needed?
None
What is being tested?
This test measures the amount of smooth muscle antibodies (SMA) in the blood. SMA are proteins produced by the body’s immune system that are directed against its own cytoskeletal proteins of the smooth muscle. Cytoskeletal proteins form the framework within a cell that serve to support or reinforce the cell structure. The production of SMA is strongly associated with chronic active autoimmune hepatitis but may also be seen in other forms of liver disease and with other autoimmune disorders such as primary biliary cirrhosis, but usually at lower titers. Autoimmune hepatitis presents as an acute or chronic inflammation of the liver that is not a result of another discernable cause – such as a viral infection, drug, toxin, hereditary disorder, or alcohol abuse. It can lead to liver cirrhosis and, in some cases, to liver failure.

Autoimmune hepatitis can be found in anyone at any age, but about 80% of those affected are women. In the United States, more than 70% of patients with this disorder will have SMA, either alone or along with ANA (antinuclear antibodies). F-actin is a specific cytoskeletal protein whereby autoantibodies directed against it may be increased. Some recent studies suggest that it is a more specific test than SMA in diagnosing autoimmune liver disease, with about 52% to 85% of those affected having the F-actin autoantibody.

How is the sample collected for testing?

A blood sample is obtained by inserting a needle into a vein in the arm.

Is any test preparation needed to ensure the quality of the sample?

No test preparation is needed.
Accordion Title
Common Questions
  • How is it used?
    The smooth muscle antibody (SMA) test is primarily ordered along with antinuclear antibodies (ANA) to help diagnose autoimmune hepatitis. Other autoantibodies, such as liver-kidney microsomal type 1 (LKM1) antibodies and antimitochondrial antibodies (AMA), may also be ordered to help diagnose autoimmune hepatitis and distinguish it from other causes of liver disease or injury.

    The anti-actin test may sometimes be ordered as an initial screening test for autoimmune hepatitis instead of the SMA test. If it is positive, it may be followed by the SMA to confirm the finding. The anti-actin test is relatively new and, in some cases, is taking the place of the SMA test. The ultimate clinical utility of the anti-actin test has yet to be established.

  • When is it ordered?
    This test and the ANA test are ordered when a doctor suspects that the patient has autoimmune hepatitis. They are usually ordered when a patient presents with symptoms such as fatigue and jaundice along with abnormal elevated findings on routine liver tests, such as aspartate aminotransferase (AST) and/or bilirubin.

    SMA and ANA are usually ordered to help diagnose and/or rule out other causes of liver injury. These causes can include viral infections, such as viral hepatitis, drugs, alcohol abuse, toxins, genetic conditions, metabolic conditions, and primary biliary cirrhosis.

  • What does the test result mean?
    When significant amounts of SMA and ANA are present in the blood, the most likely cause is autoimmune hepatitis. When both are present, then systemic lupus erythematosus, another autoimmune disorder, can be essentially ruled out as ANA will be positive with lupus but SMA is not.

    When F-actin antibodies are present in significant quantities in a patient with clinical signs of autoimmune hepatitis, then it is likely that the patient has this condition. In most cases, if the anti-actin is positive, the SMA will also be positive. Since actin is only one of several cytoskeleton proteins, it is possible for a person to have smooth muscle antibodies even when the anti-actin test is negative.

    If the SMA test is negative, then symptoms may be due to causes other than autoimmune hepatitis. However, up to 20% of patients with autoimmune hepatitis will not be positive for SMA, ANA, or LKM1 antibodies.

  • Is there anything else I should know?
    Concentrations of SMA may be lower in children and in those with compromised immune systems. The levels may vary over the course of the disease and may not be related to the severity of autoimmune symptoms or to a patient’s prognosis.

    Small amounts of SMA may be present, along with AMA, in up to 50% of patients with primary biliary cirrhosis and may be found in other conditions such as infectious mononucleosis and some cancers. F-actin antibodies may be present in about 22% of patients with primary biliary cirrhosis

    The presence of SMA, F-actin antibodies, and ANA are highly suggestive of autoimmune hepatitis but not diagnostic. When significant concentrations of both are present and the doctor suspects autoimmune hepatitis, then a liver biopsy may be performed to look for characteristic signs of damage and scarring in the liver tissue.

  • Will smooth muscle antibody (SMA) ever go away?
    If it is due to a temporary condition, such as infectious mononucleosis, SMA may drop below detectible levels once the condition has resolved. If SMA is produced because of autoimmune hepatitis, then it will be present throughout the patient's life, although levels may vary over time.
  • Can I have more than one cause of hepatitis?
    Yes. For instance, autoimmune hepatitis can co-exist with a viral hepatitis, such as hepatitis C, and can be exacerbated by liver damage caused by alcohol abuse. Since the treatment of hepatitis depends on the cause, it is very important that your doctor understand the underlying cause(s) of your condition.
  • How fast does autoimmune hepatitis progress?
    The course and severity of autoimmune hepatitis is hard to predict. It may be acute or chronic. Many patients will have no or few symptoms for many years and are diagnosed when routine liver tests are abnormal. For more information, consult with your doctor and see the related links.
View Sources
Sources Used in Current Review

Pagana, Kathleen D. & Pagana, Timothy J. (© 2007). Mosby’s Diagnostic and Laboratory Test Reference 8th Edition: Mosby, Inc., Saint Louis, MO. Pp 96-97.

Clarke, W. and Dufour, D. R., Editors (© 2006). Contemporary Practice in Clinical Chemistry: AACC Press, Washington, DC. Pp 272.

Wu, A. (© 2006). Tietz Clinical Guide to Laboratory Tests, Fourth Edition: Saunders Elsevier, St. Louis, MO. Pp 990-991.

Lee, S. (Updated 2007 May 27). Anti-smooth muscle antibody. MedlinePlus Medical Encyclopedia [On-line information]. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/003531.htm. Accessed 1/29/09.

(2008 April). Autoimmune Hepatitis. NDDIC [On-line information]. Available online at http://digestive.niddk.nih.gov/ddiseases/pubs/autoimmunehep/ through http://digestive.niddk.nig.gov. Accessed 1/29/09.

Dugdale, D. (Updated 2008 November 2). Autoimmune liver disease panel. MedlinePlus Medical Encyclopedia [On-line information]. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/003328.htm. Accessed 1/29/09.

Hill, H. et. al (Updated 2008 September). Hepatitis, Autoimmune – AIH. ARUP Consult [On-line information]. Available online at http://www.arupconsult.com/Topics/GastrointestinalDz/AIH.html# through http://www.arupconsult.com. Accessed 1/29/09.

Sources Used in Previous Reviews

Thomas, Clayton L., Editor (1997). Taber’s Cyclopedic Medical Dictionary. F.A. Davis Company, Philadelphia, PA [18th Edition].

Pagana, Kathleen D. & Pagana, Timothy J. (2001). Mosby’s Diagnostic and Laboratory Test Reference 5th Edition: Mosby, Inc., Saint Louis, MO. Pp 92-93.

Beuers, U. and Rust, C. (2005 October 27). Overlap Syndromes. Medscape, from Semin Liver Dis. 2005; 25(3): 311-320. [On-line information]. Available online at http://www.medscape.com/viewarticle/512463 through http://www.medscape.com.

Stone, C. (2004 November 10, Updated). Autoimmune liver disease panel. Medline Plus Medical Encyclopedia [On-line information]. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/003328.htm.

Peng, S. (2005 April 20). Anti-smooth muscle antibody. Medline Plus Medical Encyclopedia [On-line information]. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/003531.htm.

(© 2005). Smooth Muscle Antibody, IgG with Reflex to Titer. ARUP's Guide to Clinical Laboratory Testing [On-line information]. Available online at http://www.arup-lab.com/guides/clt/tests/clt_203b.jsp#3219875 through http://www.arup-lab.com.

Strassburg, C. and Manns, M. (2003 January 9). Autoantibodies and Autoantigens in Autoimmune Hepatitis. Medscape from Semin Liver Dis 22(4): 339 -351, 2002 [On-line journal]. Available online at http://www.medscape.com/viewarticle/445619 through http://www.medscape.com.

Czaja, A. and Freese, D. et. al. (2002 August). Diagnosis and treatment of autoimmune hepatitis. National Guideline Clearinghouse [On-line information]. Available online through http://www.guideline.gov.

(© 2005). F-Actin (Smooth Muscle) IgG by Enzyme. ImmunoassayARUP's Guide to Clinical Laboratory Testing [[On-line information]. Available online at http://www.aruplab.com/guides/clt/tests/clt_a254.jsp#5444091 through http://www.aruplab.com.

(© 2003). Actin (Smooth Muscle) Antibody. LabCorp [On-line test information]. Available online at http://www.labcorp.com/datasets/labcorp/html/chapter/mono/se018700.htm through http://www.labcorp.com.